BrightSpring Net Income From Continuing Ops from 2010 to 2025

BTSG Stock   17.32  0.02  0.12%   
BrightSpring Health's Net Loss is decreasing over the last several years with slightly volatile swings. Net Loss is estimated to finish at about -134.1 M this year. During the period from 2010 to 2025 BrightSpring Health Services, Net Loss regressed destribution of quarterly values had coefficient of variationof (541.75) and r-value of (0.70). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-141.2 M
Current Value
-134.1 M
Quarterly Volatility
68.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BrightSpring Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BrightSpring Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 187.6 M, Interest Expense of 202.4 M or Total Revenue of 6.6 B, as well as many indicators such as Price To Sales Ratio of 0.1, Dividend Yield of 0.0 or PTB Ratio of 3.04. BrightSpring financial statements analysis is a perfect complement when working with BrightSpring Health Valuation or Volatility modules.
  
Check out the analysis of BrightSpring Health Correlation against competitors.

Latest BrightSpring Health's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of BrightSpring Health Services, over the last few years. It is BrightSpring Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BrightSpring Health's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

BrightSpring Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(12,648,527)
Geometric Mean33,958,249
Coefficient Of Variation(541.75)
Mean Deviation54,463,165
Median21,151,000
Standard Deviation68,522,933
Sample Variance4695.4T
Range208.1M
R-Value(0.70)
Mean Square Error2556.3T
R-Squared0.49
Significance0
Slope(10,094,126)
Total Sum of Squares70430.9T

BrightSpring Net Income From Continuing Ops History

2025-134.1 M
2024-141.2 M
2023-156.8 M
2022-54.2 M
202151.3 M

About BrightSpring Health Financial Statements

BrightSpring Health stakeholders use historical fundamental indicators, such as BrightSpring Health's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although BrightSpring Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in BrightSpring Health's assets and liabilities are reflected in the revenues and expenses on BrightSpring Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BrightSpring Health Services,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-141.2 M-134.1 M

Currently Active Assets on Macroaxis

When determining whether BrightSpring Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if BrightSpring Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Brightspring Health Services, Stock. Highlighted below are key reports to facilitate an investment decision about Brightspring Health Services, Stock:
Check out the analysis of BrightSpring Health Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BrightSpring Health. If investors know BrightSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BrightSpring Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.333
Earnings Share
(0.22)
Revenue Per Share
61.427
Quarterly Revenue Growth
0.288
Return On Assets
0.0214
The market value of BrightSpring Health is measured differently than its book value, which is the value of BrightSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BrightSpring Health's value that differs from its market value or its book value, called intrinsic value, which is BrightSpring Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BrightSpring Health's market value can be influenced by many factors that don't directly affect BrightSpring Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BrightSpring Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrightSpring Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrightSpring Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.